Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey

Basit Öğe Kaydı
dc.authoridPaydas, Semra/0000-0003-4642-3693
dc.authoridEkinci, Ferhat/0000-0002-9317-942X
dc.authoridBulut, Gülcan/0000-0001-7382-0972
dc.authorwosidPaydas, Semra/F-3132-2018
dc.authorwosidEkinci, Ferhat/GVS-2325-2022
dc.authorwosidHizal, Mutlu/AHD-7752-2022
dc.authorwosidBulut, Gülcan/AAH-8257-2021
dc.contributor.authorSendur, M. A. N.
dc.contributor.authorCakar, B.
dc.contributor.authorHizal, M.
dc.contributor.authorEraslan, E.
dc.contributor.authorAksoy, S.
dc.contributor.authorPaydas, S.
dc.contributor.authorDemir, N.
dc.date.accessioned2023-01-12T19:54:22Z
dc.date.available2023-01-12T19:54:22Z
dc.date.issued2021
dc.departmentN/A/Departmenten_US
dc.descriptionESMO Breast Cancer Virtual Congress -- MAY 05-08, 2021 -- ELECTR NETWORKen_US
dc.description.abstract[No Abstract Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.identifier.doi10.1016/j.annonc.2021.03.138
dc.identifier.endpageS74en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.issn0923-7534en_US
dc.identifier.issn1569-8041en_US
dc.identifier.startpageS74en_US
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2021.03.138
dc.identifier.urihttps://hdl.handle.net/11454/76399
dc.identifier.volume32en_US
dc.identifier.wosWOS:000648924400128en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleTalazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkeyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu